Dr. Fei Deng will discuss recent developments in standard essential patent (SEP) litigations and FRAND royalty rate determination in China.
To register, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Dr. Fei Deng will discuss recent developments in standard essential patent (SEP) litigations and FRAND royalty rate determination in China.
To register, click here.
The rapid growth of artificial intelligence (AI) makes the build-versus-buy question particularly important. AI markets are evolving quickly, and firms must...
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
CRA is a proud sponsor of the conference. Alison Hole is a panelist during the session titled “Evolving Approaches to Merger Control in Digital and...
CRA is a proud sponsor of GCR Live: Women in Antitrust, bringing together senior practitioners, regulators, and in-house counsel to discuss key developments...
